GSK-2262167 is a potent S1P1 agonist, as effective as fingolimod in collagen-induced arthritis models, and shows good preclinical pharmacokinetic properties.

1165923-54-5

C25H26N4NaO4

469.49

GSK-2262167;GSK 2262167;GSK2262167;GSK-2262167 sodium

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years